SHI
SV Health Investors Portfolio holdings
AUM $32.3M
1-Year Return
20.15%
This Quarter Return
+65.46%
1 Year Return
-20.15%
3 Year Return
+90.94%
5 Year Return
+318.05%
10 Year Return
–
AUM
$342M
AUM Growth
+$124M
(+57%)
Cap. Flow
+$18.5M
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Sutro Biopharma
STRO
|
+$27.4M |
Top Sells
| 1 |
ASXC
Asensus Surgical, Inc.
ASXC
|
+$5.31M |
| 2 |
Ocular Therapeutix
OCUL
|
+$3.59M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
1
Tectonic Therapeutic, Inc. Common Stock
TECX
$310M
| $142M | 41.55% |
228,002
| – | – |
|
|
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $66.5M | 19.46% |
1,716,303
| – | – |
|
3
KalVista Pharmaceuticals
KALV
$688M
| $57M | 16.7% |
2,579,490
| – | – |
|
|
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
| $38.5M | 11.26% |
510,141
-70,374
| -12% | -$5.31M |
|
|
5
Sutro Biopharma
STRO
$75.3M
| $27.4M | 8.01% |
+1,824,542
| New | +$27.4M |
|
|
6
Ocular Therapeutix
OCUL
$2.18B
| $4.97M | 1.46% |
722,936
-522,334
| -42% | -$3.59M |
|
7
X4 Pharmaceuticals
XFOR
$67.1M
| $3.03M | 0.89% |
10,383
| – | – |
|
8
Astria Therapeutics
ATXS
$416M
| $2.29M | 0.67% |
47,628
| – | – |
|
|
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
| $6K | ﹤0.01% |
150,064
| – | – |
|